GLP Watchdog

Fridays vs MEDVi

MEDVi has an open FDA warning letter dated February 20, 2026. Fridays has none. On compounded semaglutide injection, MEDVi costs $600 less a year at standing rates: $199 a month against $249 a month at Fridays.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / MEDVi

Fridays logo

Fridays

5.8/10

MEDVi logo

MEDVi

7.7/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$249/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit MEDVi

Neither Fridays nor MEDVi pays us. Links to them earn nothing. Scores: Fridays 5.8, MEDVi 7.7. How we are paid

What the record shows

  1. 01

    MEDVi has an open FDA warning letter dated February 20, 2026. Fridays has none.

  2. 02

    Fridays names four pharmacies. MEDVi names three pharmacies, all 503A.

  3. 03

    On compounded semaglutide injection, MEDVi costs $600 less a year at standing rates: $199 a month against $249 a month at Fridays.

  4. 04

    Only Fridays lists a price for compounded tirzepatide injection, brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    MEDVi lists all 50 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

MEDVi

Compounded semaglutide injection

$249/mo

$2,988 a year

$199/moLower

$2,388 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

Not sold or not priced
Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None; billed monthly
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Fridays: October 30, 2026. MEDVi: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • No FDA warning letter on record
  • Sells compounded tirzepatide injection and brand-name semaglutide pen, which MEDVi does not price
  • Publishes no state list
Visit Fridays

The case for MEDVi

7.7/10
  • $600 a year less on compounded semaglutide injection
  • Open FDA warning letter, February 20, 2026
Visit MEDVi

Scores

Fridays 5.8 · MEDVi 7.7 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
6.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs MEDVi: questions

MEDVi has an open FDA warning letter dated February 20, 2026. Fridays has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. MEDVi names three pharmacies, all 503A. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
MEDVi, by $600 a year at standing rates. Fridays: $249 a month, about $2,988 a year. MEDVi: $199 a month, about $2,388 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. MEDVi states you can cancel at any time; refunds: full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed.
Neither Fridays nor MEDVi pays us. Links to them earn nothing. Scores: Fridays 5.8, MEDVi 7.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks